Primary treatment of prostate cancer using 1.5  T MR-linear accelerator

CONCLUSIONS: MR-Linacs expand the spectrum of radiotherapeutic options for prostate cancer. Increased precision can be reached with daily MRI-based target volume definition and plan adaption. Clinical studies are necessary to identify patient groups who would benefit most from radiotherapy on a MR-Linac.PMID:34297139 | DOI:10.1007/s00117-021-00882-8

Source: Der Radiologe - July 23, 2021 Category: Radiology Authors: Daniel Wegener Daniel Zips Cihan Gani Simon Boeke Konstantin Nikolaou Ahmed E Othman Haidara Almansour Frank Paulsen Arndt-Christian M üller Source Type: research